The exploration of PON2’s role in cardioprotection reveals its potential in mitigating heart failure, both in experimental models and human contexts, posited to stem from its adeptness in enhancing mitochondrial function and attenuating reactive oxygen species (ROS) generation (47). This evidence concerns the gene PON2 and heart failure.